Urogen Pharma (URGN) Ownership - Who Owns Urogen Pharma?

655 Followers

Urogen Pharma (URGN) Ownership Overview

1.95% Insiders

6.11% Mutual Funds

0.39% Other Institutional Investors

6.92% ETFs

84.63% Public Companies and

Individual Investors

The ownership structure of Urogen Pharma (URGN) stock is a mix of institutional, retail, and individual investors. Approximately 13.42% of the company’s stock is owned by Institutional Investors, 1.95% is owned by Insiders, and 84.63% is owned by Public Companies and Individual Investors.

The ownership structure of Urogen Pharma (URGN) stock is a mix of institutional, retail, and individual investors. Approximately 6.50% of the company’s stock is owned by Institutional Investors, 1.95% is owned by Insiders, and 6.92% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Feb 04, 2026	Mark Schoenberg	xxxxxxxxxxxxx	$145174
Aug 13, 2025	Mark Schoenberg	xxxxxxxxxxxxx	$176900

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Ark Investment Management Llc	xxxxxxxxxxxxx	$2845155
Dec 31, 2023	Aisling Capital Management Lp	xxxxxxxxxxxxx	$2529360
Dec 31, 2023	Woodline Partners Lp	xxxxxxxxxxxxx	$11727003

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	1,780,467	Institution	3.66%	40,950,741
	918,067	Institution	1.89%	21,115,541
Michael Rockefeller	500,726	Institution	1.03%	11,516,698
Len Potter	495,606	Institution	1.02%	11,398,938
	460,590	Institution	0.95%	10,593,570
	459,055	Institution	0.94%	10,558,265
	408,693	Insider	0.84%	9,399,939
	386,778	Institution	0.79%	8,895,894
	376,661	Institution	0.77%	8,663,203
	343,389	Institution	0.71%	7,897,947

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
918,067	Institution	1.89%	21,115,541
459,055	Institution	0.94%	10,558,265
386,778	Institution	0.79%	8,895,894
343,389	Institution	0.71%	7,897,947
146,990	Institution	0.30%	3,380,770
118,186	Institution	0.24%	2,718,278
115,523	Institution	0.24%	2,657,029
108,843	Institution	0.22%	2,503,389
92,483	Institution	0.19%	2,127,109
60,166	Institution	0.12%	1,383,818

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Russell 2000 ETF	949,875	Institution	1.95%	21,847,125
iShares Biotechnology ETF	285,217	Institution	0.59%	6,559,991
iShares Russell 2000 Growth ETF	270,574	Institution	0.56%	6,223,202
Vanguard Russell 2000 ETF	198,150	Institution	0.41%	3,562,737
SPDR Portfolio Developed World ex-US ETF	184,862	Institution	0.38%	4,405,261
Fidelity Enhanced Small Cap ETF	163,961	Institution	0.34%	3,907,191
Vanguard Health Care ETF	117,713	Institution	0.24%	2,116,480
Xtrackers S&P 500 Swap UCITS ETF	107,301	Institution	0.22%	2,504,405
Xtrackers S&P 500 Swap UCITS ETF 5C-EUR Hedged	107,301	Institution	0.22%	2,504,405
Xtrackers S&P 500 Swap UCITS ETF	107,301	Institution	0.22%	2,504,405

FAQ

Who Owns Urogen Pharma (URGN)?

According to the latest TipRanks data, approximately 0.39% of the company's stock is held by institutional investors, 1.95% is held by insiders, and 84.63% is held by retail investors.

What percentage of Urogen Pharma (URGN) stock is held by institutional investors?

According to the latest TipRanks data, approximately 0.39% of Urogen Pharma (URGN) stock is held by institutional investors.

What percentage of Urogen Pharma (URGN) stock is held by retail investors?

According to the latest TipRanks data, approximately 84.63% of Urogen Pharma (URGN) stock is held by retail investors.

Who owns the most shares of Urogen Pharma (URGN)?

iShares owns the most shares of Urogen Pharma (URGN).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.